Genofocus is a company that develops new microbiome drugs, develops/produces industrial special enzymes using microbial metabolism.
Genofocus has platform technology required for economy of scale production for enzyme production, with respective technologies and facilities to maximize enzyme efficiency by improving host microorganism quickly and precisely.
Genofocus is developing and producing variety of industrial special enzymes based on core-technologies and accumulated know-hows.
Genofocus is taking a step further by developing next-generation microbiome new drugs.
Eui Joong, Kim
Founder & CTO
Director of research institute.
Chairman of the New Drug Advisory Committee.
Director of Planning.
Quality control director.